The functional review and acceptance scope of health food is stipulated by the Ministry of Health. Currently, 22 types of functions are officially accepted as health food functions. These 22 functions are: 1. Helps to enhance immunity; 2. Helps to lower blood sugar; 3. Helps to lower blood lipids; 4. Helps to improve gastrointestinal function; 5. Helps to improve memory; 6 .Helping to relieve visual fatigue; 7. Helping to eliminate lead; 8. Clearing the throat; 9. Helping to improve sleep; 10. Helping lactation; 11. Helping to improve hypoxia tolerance; 12. Helps relieve exercise fatigue; 13. Antioxidant; 14. Helps reduce body fat; 15. Helps increase bone density 16. Helps improve iron deficiency anemia; 17. Helps reduce alcoholic liver damage Hazards; 18. Helps to promote the health of facial skin; the main function of nattokinase is to dissolve blood clots. It does not have the function of dissolving blood clots in the health food function acceptance project. Therefore, nattokinase products do not have a "blue hat".
The discovery of nattokinase came from the famous "two-thirty experiment". One day in 1980, Dr. Yoko Sumi, a Japanese cardiovascular and cerebrovascular expert engaged in research on thrombolytic drugs, suddenly remembered that natto is not a fiber. Is the protein fermented? The most stubborn part of thrombus is fibrin, so at 2:30 in the afternoon, Dr. Yangxing added substances extracted from natto to the artificial thrombus. I was originally planning to see the results the next day, but at 5:30, I made an accidental inspection and a miracle happened. The thrombus actually dissolved by 2 centimeters. However, it usually takes nearly two days to dissolve 2 centimeters in a thrombolytic experiment using urokinase. Time, that is to say, the speed at which natto fermentation dissolves thrombus is 19 times that of urokinase. Therefore, this powerful thrombolytic substance of Natto was named Nattokinase, or NK for short. This was the famous "2:30 PM" experiment in the history of thrombolytic drug research that shocked the world. On December 20, 2010, the world's authoritative nattokinase organization - the Japanese Nattokinase Association and the nattokinase patent owner - the Japan Institute of Biological Sciences invited the China National Medical Education Development Center to hold a press conference at the Media Center in Beijing meeting and issued a statement: Japan Bioscience Research Institute is the largest nattokinase raw material manufacturer in Japan and the world, and is the only one with the nattokinase production patent granted by the Japan Patent Office (Patent No. 3881494). The nattokinase developed by the institute is produced by fermentation of Natto bacteria culture broth, and is extracted and purified through special technology and processes. The high-purity nattokinase product made from this substance as the main raw material has a thrombolytic effect. It is a high-tech product in the field of modern biology. Its safety and effectiveness have been verified by medical clinical trials and have also been approved by Japanese Natto. Fully endorsed by the Kinase Association. The statement said that although Professor Sumi Yoko of Japan was the discoverer of the thrombolytic effect of nattokinase, he himself did not have the right to grant the manufacturer the right to produce nattokinase. Except for the Japan Institute of Biological Sciences, the production of nattokinase by any other company or individual may involve infringement of the institute's product patents and legitimate rights and interests. In addition, the standard unit for nattokinase products set by the Japan Official Health and Nutrition Food Association is "FU" instead of "IU".